Veterans and service members with PTSD would get a new therapy option through VA and DoD.
The TREAT PTSD Act would require the Department of Veterans Affairs (VA) and the Department of Defense (DoD) to offer a specific therapy called stellate ganglion block. This therapy would be for eligible veterans and active and reserve service members diagnosed with post-traumatic stress disorder (PTSD). Individuals who meet the criteria could choose to receive this treatment, which is not currently a mandated offering.
Currently, the Department of Veterans Affairs and the Department of Defense are not explicitly required by law to provide stellate ganglion block therapy for post-traumatic stress disorder. If this bill becomes law, both departments would be mandated to offer this therapy to eligible veterans and service members, and their clinical guidelines for PTSD would be updated to reflect this option.
HR 1947 · 119th Congress · March 6, 2025 · AI Summary by gemini-2.5-flash · 9/10
Sign in to see your representatives' phone numbers
1 filings mentioned this bill
Amounts reflect total quarterly lobbying spend reported to the Senate, not bill-specific spending. Source: Senate LDA filings.